Package 68071-3695-3

{"route": ["ORAL"], "spl_id": "2a31e80a-2d19-b23c-e063-6394a90a1aec", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "upc": ["0368071369533"], "unii": ["G70B4ETF4S", "OTT9J7900I"], "rxcui": ["476556"], "spl_set_id": ["23ae0a72-adcf-fdd0-e063-6394a90abe63"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "3 TABLET, FILM COATED in 1 BOTTLE (68071-3695-3)", "package_ndc": "68071-3695-3", "marketing_start_date": "20241004"}], "brand_name": "Emtricitabine and tenofovir disoproxil fumarate", "product_id": "68071-3695_2a31e80a-2d19-b23c-e063-6394a90a1aec", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "68071-3695", "generic_name": "Emtricitabine and tenofovir disoproxil fumarate", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and tenofovir disoproxil fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA203442", "marketing_category": "ANDA", "marketing_start_date": "20220309", "listing_expiration_date": "20261231"}